We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.


Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App

Next-Gen Miniaturized, Leadless Pacemakers Offer Longer Battery Life and Easier Programming

By HospiMedica International staff writers
Posted on 02 May 2023
Print article
Image: The Micra AV and Micra VR transcatheter pacing systems (Photo courtesy of Medtronic)
Image: The Micra AV and Micra VR transcatheter pacing systems (Photo courtesy of Medtronic)

Heart block, also known as atrioventricular (AV) block, is a condition where the electrical signals between the heart's chambers (the atria and the ventricles) are disrupted. Historically, patients with AV block have been treated with conventional dual-chamber pacemakers, which are implanted in the upper chest, beneath the skin below the collarbone, and connected to the heart with thin wires called "leads." Over their roughly 60-year history, pacemakers have seen significant advancements, including miniaturization, improvements in pacing technology, MRI compatibility, and remote monitoring. Now, the latest generation of industry-leading miniaturized, leadless pacemakers offers a 40% longer battery life than their predecessors, along with numerous other benefits.

Micra AV2 and Micra VR2, the world's smallest pacemakers, from Medtronic plc (Dublin, Ireland) provide approximately 40% more battery life and easier programming than previous Micra pacemakers while retaining the many advantages of leadless pacing, such as reduced complications compared to traditional pacemakers. Similar in size to a multivitamin, Micra pacemakers are less than one-tenth the size of conventional pacemakers. Micra pacemakers eliminate the need for leads or a surgical "pocket" under the skin, thereby removing potential sources of complications related to leads and pockets, and leaving no visible indication of the device.

The Micra AV2 and Micra VR2 boast approximately 40% more battery life compared to previous generations, with a median projected battery life of nearly 16 and 17 years, respectively. This means that over 80% of patients who receive the pacemaker are expected to only need one device for life. The new Micra AV2 also features advanced algorithms that automatically program AV synchrony, thereby coordinating the heart's upper and lower chambers. Additionally, for active patients, the Micra AV2 offers a higher available tracking capability for faster heart rates (increased from 115 to 135 beats per minute for upper limits).

"Our goal is to improve the patient experience by continuously reinventing our ground-breaking leadless pacemaker," said Robert C. Kowal, M.D., Ph.D., general manager, Cardiac Pacing Therapies within the Cardiac Rhythm Management business, which is part of the Cardiovascular Portfolio at Medtronic. "Since inventing the first battery-operated cardiac pacemakers 65 years ago, Medtronic has transformed pacing technologies to benefit patients, including the nearly 200,000 patients globally who have received a Micra device so far."

Related Links:
Medtronic plc 

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
Traumatic Brain Injury Whole Blood Test

Print article


Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.